Shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $161.10, but opened at $145.50. Krystal Biotech shares last traded at $156.83, with a volume of 263,735 shares. Wall Street Analysts Forecast Growth KRYS has been the topic of several research […]
Stifel Nicolaus reaffirmed their buy rating on shares of Krystal Biotech (NASDAQ:KRYS – Free Report) in a research report released on Tuesday, Benzinga reports. They currently have a $204.00 price target on the stock, up from their prior price target of $178.00. Other research analysts have also recently issued reports about the stock. William Blair […]
China Universal Asset Management Co. Ltd. lifted its position in Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 353.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,259 shares of the company’s stock after buying an additional 2,541 shares during the […]
Krystal Biotech (NASDAQ:KRYS – Get Free Report) posted its quarterly earnings data on Monday. The company reported $0.30 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.52) by $0.82, MarketWatch Earnings reports. The company had revenue of $42.14 million for the quarter, compared to analysts’ expectations of $27.43 million. During the same […]
Los Angeles Capital Management LLC reduced its position in shares of Krystal Biotech, Inc. (NASDAQ:KRYS – Free Report) by 36.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,123 shares of the company’s stock after selling 5,839 […]